Regulatory tumor-infiltrating lymphocytes prevail in endometrial tumors with low vascular survival ability

Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?

(2020) Elena García-Martínez et al.   ANGIOGENESIS

Immune disorder in endometrial cancer: Immunosuppressive microenvironment, mechanisms of immune evasion and immunotherapy (Review)

(2020) Lei Zhan et al.   Oncology Letters

Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity

(2020) Won Suk Lee et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Antiangiogenic therapy: Markers of response, “normalization” and resistance

(2018) Karima El Alaoui-Lasmaili et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Effects of different hypoxia degrees on endothelial cell cultures—Time course study

(2018) Ioana Baldea et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

(2018) Dai Fukumura et al.   Nature Reviews Clinical Oncology

Improvements in Progression-Free and Overall Survival Due to the Use of Anti-Angiogenic Agents in Gynecologic Cancers

(2015) Bernd C. Schmid et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity

(2015) Jee H. Lee et al.   IMMUNITY

Tumor Vasculature Is Regulated by FGF/FGFR Signaling-Mediated Angiogenesis and Bone Marrow-Derived Cell Recruitment: This Mechanism Is Inhibited by SSR128129E, the First Allosteric Antagonist of FGFRs

(2014) Pierre Fons et al.   JOURNAL OF CELLULAR PHYSIOLOGY

In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model

(2012) XIAOHUI DU et al.   ONCOLOGY REPORTS

Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa

(2012) E. T. Clambey et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

New pathways and mechanisms regulating and responding to Delta-like ligand 4–Notch signalling in tumour angiogenesis

(2011) Chern Ein Oon et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy

(2009) Joshua I Greenberg et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α

(2008) Jeremy Ben-Shoshan et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer

(2008) Alexandra Giatromanolaki et al.   GYNECOLOGIC ONCOLOGY

Provascular strategy: Targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment

(2008) Pierre Sonveaux   RADIOTHERAPY AND ONCOLOGY